Real-time enrollment status for this invasive mold infections clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:05 PM UTC
| NCT Number | NCT06925321 |
| Recruiting Status | Recruiting |
| Condition | Invasive Mold Infections |
| Phase | PHASE3 |
| Target Enrollment | 234 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Basilea Pharmaceutica |
| Last Updated on CT.gov | September 14, 2026 (4 weeks ago) |
As of October 12, 2026: Clinical trial NCT06925321 is currently recruiting participants. This phase3 study for invasive mold infections is actively seeking new participants at 20 locations across the United States. The study is sponsored by Basilea Pharmaceutica. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06925321 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06925321 was last updated 4 weeks ago (September 14, 2026). HelloStudys verifies this status automatically.